業績

1998年(平成10)業績

(英文)

  1. Izumikawa K, Hirakata Y, Yamaguchi T, Yoshida R, Nakano M, Matsuda J, Mochida C, Maesaki S, Tomono K, Yamada Y, Tashiro T, Kohno S, and Kamihira S. Analysis of genetic relationships and antimicrobial susceptibility of verotoxin-producing Escherichia coli strains isolated in Nagasaki Prefecture, Japan in 1996. Microbiol Immunol. 42:***********.
  2. Izumikawa K, Hirakata Y, Yamaguchi T, Takemura H, Maesaki S, Tomono K, Igimi S, Kaku M, Yamada Y, Kohno S, and Kamihira S. Escherichia coli O157 interactions with human intestinal Caco-2 cells and the influence of fosfomycin. J Antimicrob Chemother. 42:341-7 1998.
  3. Hirakata Y, Izumikawa K, Yamaguchi T, Takemura H, Tanaka H, Yoshida R, Matsuda J, Nakano M, Tomono K, Maesaki S, Kaku M, Yamada Y, Kamihira S, and Kohno S. Rapid detection and evaluation of clinical characteristics of emerging multiple-drug-resistant gram-negative rods carrying the metallo-beta lactamase gene blaIMP. Antimicrob Agents Chemother 42:2006-11 1998.
  4. Hirakata Y, Izumikawa K, Yamaguchi T, Igimi S, Furuya N, Maesaki S, Tomono K, Yamada Y, Kohno S, Yamaguchi K, and Kamihira S. Adherence to and penetration of human intestinal Caco-2 epithelial cell monolayers by Pseudomonas aeruginosa. Infect Immun 66:1748-51 1998.
  5. Izumikawa K, Hirakata Y, Yamaguchi T, Yoshida R, Tanaka H, Takemura H, Maesaki S, Tomono K, Kaku M, Izumikawa KI, Kamihira S, and Kohno S. In vitro activities of quinupristin-dalfopristin and the streptogramin RPR 106972 against Mycoplasma pneumoniae. Antimicrob Agents Chemother 42: 698-9 1998.